# ALK-Abelló A/S clinical trials: 67 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 67 trials with ALK-Abelló A/S as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by ALK-Abelló A/S: 67 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/alk-abell-a-s

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 67
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 67, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 11, 2025 | NCT07060885 | A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 | ALK-Abelló A/S | Phase 3 | Completed | Allergic Rhinoconjunctivitis, Allergic Rhinitis | 327 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07060885) |
| November 30, 2023 | NCT06151938 | Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis | ALK-Abelló A/S | Observational | Unknown | Allergic Rhinitis Due to House Dust Mite, Allergic Asthma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06151938) |
| May 31, 2023 | NCT05881577 | The Effect of Allergic Rhinitis on Educational Outcomes | ALK-Abelló A/S | Observational | Unknown | Allergic Rhinitis | 150,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05881577) |
| December 19, 2022 | NCT05655858 | Observational Study of Allergic Rhinitis in Children | ALK-Abelló A/S | Observational | Completed | Allergic Rhinitis | 1,004 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05655858) |
| July 27, 2022 | NCT05476484 | Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma | ALK-Abelló A/S | Observational | Completed | Allergic Rhinitis, Asthma, Allergy | 46,196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05476484) |
| July 1, 2022 | NCT05440643 | Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy | ALK-Abelló A/S | Phase 1/2 | Completed | Peanut Allergy | 209 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05440643) |
| May 11, 2021 | NCT04881461 | A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis | ALK-Abelló A/S | Phase 3 | Completed | Allergy | 445 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04881461) |
| May 7, 2021 | NCT04878354 | A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis | ALK-Abelló A/S | Phase 3 | Completed | Allergy | 952 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04878354) |
| September 9, 2020 | NCT04541004 | Adolescent Mite Allergy Safety Evaluation | ALK-Abelló A/S | Phase 3 | Completed | Allergic Rhinitis, Allergic Rhinoconjunctivitis | 253 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04541004) |
| November 25, 2019 | NCT04176185 | A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber | ALK-Abelló A/S | Phase 3 | Terminated | Allergic Rhinoconjunctivitis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04176185) |
| October 30, 2019 | NCT04145219 | House Dust Mite Allergy Trial In Children | ALK-Abelló A/S | Phase 3 | Completed | Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic... | 1,460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04145219) |
| October 14, 2019 | NCT04125888 | Impact of AIT on Allergic Rhinitis and Asthma | ALK-Abelló A/S | Observational | Completed | Allergy, Respiratory Disease | 92,048 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04125888) |
| November 20, 2018 | NCT03746860 | N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France | ALK-Abelló A/S | Observational | Completed | Allergic Rhinitis Due to House Dust Mite, Allergic Asthma Due to Dermatophagoides Farinae, Allergic Asthma Due to... | 1,508 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03746860) |
| August 31, 2018 | NCT03654976 | Mite Asthma Pediatric Immunotherapy Trial | ALK-Abelló A/S | Phase 3 | Completed | Allergic Asthma Due to Dermatophagoides Farinae, Allergic Asthma Due to Dermatophagoides Pteronyssinus, Allergic... | 533 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03654976) |
| June 25, 2015 | NCT02481856 | A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber | ALK-Abelló A/S | Phase 2 | Completed | Allergic Rhinoconjunctivitis | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02481856) |
| May 8, 2015 | NCT02437786 | Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® | ALK-Abelló A/S | Phase 4 | Completed | Allergic Rhinoconjunctivitis | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02437786) |
| October 3, 2014 | NCT02256553 | Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607... | ALK-Abelló A/S | Phase 4 | Completed | Rhinitis, Allergic, Seasonal | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02256553) |
| June 18, 2014 | NCT02166268 | Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an... | ALK-Abelló A/S | Phase 2 | Completed | Grass Pollen Induced Allergic Rhinoconjunctivitis | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02166268) |
| February 24, 2014 | NCT02069535 | An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy | ALK-Abelló A/S | Phase 2 | Completed | Allergic Rhinoconjunctivitis | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02069535) |
| February 19, 2014 | NCT02065856 | An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy | ALK-Abelló A/S | Phase 2 | Completed | Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02065856) |
| May 15, 2013 | NCT01854736 | Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate | ALK-Abelló A/S | Phase 4 | Completed | Allergic Rhinitis Due to Grass Pollens | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01854736) |
| December 4, 2012 | NCT01740284 | A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine | ALK-Abelló A/S | Phase 3 | Completed | Allergic Rhinoconjunctivitis | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01740284) |
| November 19, 2012 | NCT01728298 | A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy | ALK-Abelló A/S | Phase 2 | Completed | Allergic Rhinitis | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01728298) |
| November 19, 2012 | NCT01728285 | Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis | ALK-Abelló A/S | Phase 3 | Completed | Allergic Rhinitis, Grass Allergy | 261 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01728285) |
| October 4, 2012 | NCT01700192 | Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis... | ALK-Abelló A/S | Phase 3 | Completed | Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal | 1,482 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01700192) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 1 |
| Phase 2 | 13 |
| Phase 2/3 | 8 |
| Phase 3 | 27 |
| Phase 4 | 5 |
| Observational | 8 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 63 |
| Unknown | 2 |
| Terminated | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hypersensitivity | 27 |
| Rhinitis, Allergic | 16 |
| Rhinitis | 10 |
| Asthma | 8 |
| Conjunctivitis | 7 |
| Rhinitis, Allergic, Perennial | 5 |
| Rhinitis, Allergic, Seasonal | 3 |
| Peanut Hypersensitivity | 1 |
| Dermatitis, Atopic | 1 |
| Conjunctivitis, Allergic | 1 |
| Dust Mite Allergy | 1 |
| Respiration Disorders | 1 |
| Patient Compliance | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Soup restaurants in the United States](https://specstream.ai/data/businesses/soup-restaurants/united-states)
- [Smoothie and juice bars in the United States](https://specstream.ai/data/businesses/smoothie-and-juice-bars/united-states)
- [Siding contractors in the United States](https://specstream.ai/data/businesses/siding-contractors/united-states)
- [Sheet metal fabricators in the United States](https://specstream.ai/data/businesses/sheet-metal-fabricators/united-states)
- [Security companies in the United States](https://specstream.ai/data/businesses/security-companies/united-states)
- [Scandinavian restaurants in the United States](https://specstream.ai/data/businesses/scandinavian-restaurants/united-states)
